ARTICLE | Company News
PDL BioPharma, Eli Lilly deal
January 4, 2010 8:00 AM UTC
Eli Lilly received a non-exclusive license to PDL's Queen et al. patents related to teplizumab and other potential next generation anti-CD3 molecules. Lilly and MacroGenics Inc. (Rockville, Md.) are...